About zPREDICTA

zPREDICTA’s bio-simulation technology combines biology with automation and computation to automate drug development. zPREDICTA's bio-simulation platform enables pharma to rapidly identify drug candidates that will be effective in patients. r-Organ is a set of next generation 3D culture models that provide 1-to-1 reconstruction of human tissue microenvironment in an organ- and disease-specific manner allowing accurate prediction of drug response. Utilizing r-Organ technology, zPREDICTA is mappi

Company Highlights
Year Founded

2014

icon-altEmployees

1

Location (HQ)

USA

Since Last Funding

8 years 3 months

Monthly Website Visitors

6.5K

icon-altTotal Investment Amt

$100K

Last Funding Round

Seed

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Health Care

Biotechnology

Biotechnology Research